Public-registry site landscape for NCT04855721, a Plaque Psoriasis study sponsored by Aurigene Discovery Technologies Limited. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04855721 (registry record) |
| Sponsor | Aurigene Discovery Technologies Limited |
| Condition(s) | Plaque Psoriasis |
| Phase | PHASE2 |
| Listed sites | 25 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04855721 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →